{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T12:15:22Z","timestamp":1781525722207,"version":"3.54.1"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T00:00:00Z","timestamp":1707177600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"National High Level Hospital Clinical Research Funding","award":["2022-PUMCH-B-021"],"award-info":[{"award-number":["2022-PUMCH-B-021"]}]},{"name":"Sansheng Yeehong TCP Research Foundation"},{"DOI":"10.13039\/100016966","name":"Bethune Charitable Foundation","doi-asserted-by":"publisher","award":["J202103E006"],"award-info":[{"award-number":["J202103E006"]}],"id":[{"id":"10.13039\/100016966","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10557-024-07558-0","type":"journal-article","created":{"date-parts":[[2024,2,6]],"date-time":"2024-02-06T07:02:00Z","timestamp":1707202920000},"page":"563-572","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Acute Kidney Injury in Different Anticoagulation Strategies: A Large-Scale Pharmacoepidemiologic Study Using Real-World Data"],"prefix":"10.1007","volume":"39","author":[{"given":"Qiuyu","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9629-8320","authenticated-orcid":false,"given":"Gang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanxi","family":"Ai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,6]]},"reference":[{"issue":"12","key":"7558_CR1","doi-asserted-by":"publisher","first-page":"2787","DOI":"10.1681\/ASN.2018070741","volume":"29","author":"S Brodsky","year":"2018","unstructured":"Brodsky S, Eikelboom J, Hebert LA. Anticoagulant-related nephropathy. J Am Soc Nephrol. 2018;29(12):2787. https:\/\/doi.org\/10.1681\/ASN.2018070741","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"7558_CR2","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1053\/j.ajkd.2009.04.024","volume":"54","author":"SV Brodsky","year":"2009","unstructured":"Brodsky SV, et al. Acute kidney injury during warfarin therapy associated with obstructive tubular red blood cell casts: a report of 9 cases. Am J Kidney Dis. 2009;54(6):1121\u20136. https:\/\/doi.org\/10.1053\/j.ajkd.2009.04.024","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"7558_CR3","doi-asserted-by":"publisher","first-page":"935","DOI":"10.2215\/CJN.02470319","volume":"14","author":"RJ Glassock","year":"2019","unstructured":"Glassock RJ. Anticoagulant-related nephropathy: it\u2019s the real McCoy. Clin J Am Soc Nephrol. 2019;14(6):935. https:\/\/doi.org\/10.2215\/CJN.02470319","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"7558_CR4","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/s0272-6386(00)70209-5","volume":"35","author":"AB Abt","year":"2000","unstructured":"Abt AB, Carroll LE, Mohler JH. Thin basement membrane disease and acute renal failure secondary to gross hematuria and tubular necrosis. Am J Kidney Dis. 2000;35(3):533\u20136. https:\/\/doi.org\/10.1016\/s0272-6386(00)70209-5","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"7558_CR5","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1093\/ckj\/sfw133","volume":"10","author":"L Golbin","year":"2017","unstructured":"Golbin L, et al. Warfarin-related nephropathy induced by three different vitamin K antagonists: analysis of 13 biopsy-proven cases. Clin Kidney J. 2017;10(3):381\u20138. https:\/\/doi.org\/10.1093\/ckj\/sfw133","journal-title":"Clin Kidney J"},{"issue":"21","key":"7558_CR6","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/j.jacc.2016.09.926","volume":"68","author":"SV Brodsky","year":"2016","unstructured":"Brodsky SV, Hebert LA. Anticoagulant-related nephropathy: is an AKI elephant hiding in plain view? J Am Coll Cardiol. 2016;68(21):2284\u20136. https:\/\/doi.org\/10.1016\/j.jacc.2016.09.926","journal-title":"J Am Coll Cardiol"},{"key":"7558_CR7","doi-asserted-by":"publisher","unstructured":"Brodsky SV, et al. Acute kidney injury aggravated by treatment initiation with apixaban: Another twist of anticoagulant-related nephropathy. Kidney Res Clin Pract. 2017;36(4):387. https:\/\/doi.org\/10.23876\/j.krcp.2017.36.4.387","DOI":"10.23876\/j.krcp.2017.36.4.387"},{"issue":"3","key":"7558_CR8","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1080\/08998280.2018.1463036","volume":"31","author":"L Jansky","year":"2018","unstructured":"Jansky L, et al. Acute kidney injury and undiagnosed immunoglobulin A nephropathy after dabigatran therapy. Proc (Bayl Univ Med Cent). 2018;31(3):321\u20133. https:\/\/doi.org\/10.1080\/08998280.2018.1463036","journal-title":"Proc (Bayl Univ Med Cent)"},{"issue":"4","key":"7558_CR9","first-page":"173","volume":"112","author":"ST Shafi","year":"2013","unstructured":"Shafi ST, et al. A case of dabigatran-associated acute renal failure. WMJ. 2013;112(4):173\u20135.","journal-title":"WMJ"},{"issue":"1","key":"7558_CR10","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.annfar.2013.11.011","volume":"33","author":"B Bachellerie","year":"2014","unstructured":"Bachellerie B, et al. Patient with acute renal injury presenting dabigatran overdose: hemodialysis for surgery. Ann Fr Anesth Reanim. 2014;33(1):44\u20136. https:\/\/doi.org\/10.1016\/j.annfar.2013.11.011","journal-title":"Ann Fr Anesth Reanim"},{"issue":"3","key":"7558_CR11","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1093\/ckj\/sfy133","volume":"12","author":"KB de Aquino Moura","year":"2019","unstructured":"de Aquino Moura KB, et al. Anticoagulant-related nephropathy: systematic review and meta-analysis. Clin Kidney J. 2019;12(3):400\u20137. https:\/\/doi.org\/10.1093\/ckj\/sfy133","journal-title":"Clin Kidney J"},{"issue":"2","key":"7558_CR12","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s11239-018-1669-3","volume":"46","author":"V L\u2019Imperio","year":"2018","unstructured":"L\u2019Imperio V, et al. Anticoagulant-related nephropathy: a pathological note. J Thromb Thrombolysis. 2018;46(2):260\u20133. https:\/\/doi.org\/10.1007\/s11239-018-1669-3","journal-title":"J Thromb Thrombolysis"},{"issue":"2","key":"7558_CR13","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/ki.2011.44","volume":"80","author":"SV Brodsky","year":"2011","unstructured":"Brodsky SV, et al. Warfarin-related nephropathy occurs in patients with and without chronic kidney disease and is associated with an increased mortality rate. Kidney Int. 2011;80(2):181\u20139. https:\/\/doi.org\/10.1038\/ki.2011.44","journal-title":"Kidney Int"},{"issue":"2","key":"7558_CR14","doi-asserted-by":"publisher","first-page":"c142","DOI":"10.1159\/000312877","volume":"115","author":"SV Brodsky","year":"2010","unstructured":"Brodsky SV, et al. Warfarin therapy that results in an International Normalization Ratio above the therapeutic range is associated with accelerated progression of chronic kidney disease. Nephron Clin Pract. 2010;115(2):c142\u20136. https:\/\/doi.org\/10.1159\/000312877","journal-title":"Nephron Clin Pract"},{"issue":"4","key":"7558_CR15","doi-asserted-by":"publisher","first-page":"e57661","DOI":"10.1371\/journal.pone.0057661","volume":"8","author":"JN An","year":"2013","unstructured":"An JN, et al. The occurrence of warfarin-related nephropathy and effects on renal and patient outcomes in korean patients. PLoS ONE. 2013;8(4):e57661. https:\/\/doi.org\/10.1371\/journal.pone.0057661","journal-title":"PLoS ONE"},{"key":"7558_CR16","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s11255-017-1527-9","volume":"49","author":"RG Kalaitzidis","year":"2017","unstructured":"Kalaitzidis RG, et al. Anticoagulant-related nephropathy: a case report and review of the literature of an increasingly recognized entity. Int Urol Nephrol. 2017;49:1401\u20137. https:\/\/doi.org\/10.1007\/s11255-017-1527-9","journal-title":"Int Urol Nephrol"},{"issue":"2","key":"7558_CR17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.xkme.2019.03.002","volume":"1","author":"SV Brodsky","year":"2019","unstructured":"Brodsky SV, et al. Anticoagulant-related nephropathy in kidney biopsy: a single-center report of 41 cases. Kidney Med. 2019;1(2):51\u20136. https:\/\/doi.org\/10.1016\/j.xkme.2019.03.002","journal-title":"Kidney Med"},{"key":"7558_CR18","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s11255-012-0364-0","volume":"45","author":"AK Lim","year":"2013","unstructured":"Lim AK, Campbell DA. Haematuria and acute kidney injury in elderly patients admitted to hospital with supratherapeutic warfarin anticoagulation. Int Urol Nephrol. 2013;45:561\u201370. https:\/\/doi.org\/10.1007\/s11255-012-0364-0","journal-title":"Int Urol Nephrol"},{"key":"7558_CR19","doi-asserted-by":"publisher","unstructured":"Brodsky S et al. Increased INR> 3.0 in patients on warfarin therapy is associated with acute changes in the serum creatinine and increased mortality rate. Blood. 2010;116(21):819. https:\/\/doi.org\/10.1182\/blood.V116.21.819.819","DOI":"10.1182\/blood.V116.21.819.819"},{"key":"7558_CR20","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.thromres.2022.12.002","volume":"222","author":"S Chen","year":"2023","unstructured":"Chen S, et al. Anticoagulant-related nephropathy induced by direct-acting oral anticoagulants: Clinical characteristics, treatments and outcomes. Thromb Res. 2023;222:20\u20133. https:\/\/doi.org\/10.1016\/j.thromres.2022.12.002","journal-title":"Thromb Res"},{"issue":"7","key":"7558_CR21","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1111\/bcp.14688","volume":"87","author":"S Mitsuboshi","year":"2021","unstructured":"Mitsuboshi S, et al. Differences in risk factors for anticoagulant-related nephropathy between warfarin and direct oral anticoagulants: Analysis of the Japanese adverse drug event report database. Br J Clin Pharmacol. 2021;87(7):2977\u201381. https:\/\/doi.org\/10.1111\/bcp.14688","journal-title":"Br J Clin Pharmacol"},{"issue":"4","key":"7558_CR22","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1053\/j.ajkd.2015.02.337","volume":"66","author":"ME Grams","year":"2015","unstructured":"Grams ME, et al. A meta-analysis of the association of estimated GFR, albuminuria, age, race, and sex with acute kidney injury. Am J Kidney Dis. 2015;66(4):591\u2013601. https:\/\/doi.org\/10.1053\/j.ajkd.2015.02.337","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"7558_CR23","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1161\/01.cir.100.6.587","volume":"100","author":"A Greinacher","year":"1999","unstructured":"Greinacher A, et al. Lepirudin (recombinant hirudin) for parenteral anticoagulation in patients with heparin-induced thrombocytopenia. Circulation. 1999;100(6):587\u201393. https:\/\/doi.org\/10.1161\/01.cir.100.6.587","journal-title":"Circulation"},{"issue":"8","key":"7558_CR24","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1517\/17425255.4.8.1131","volume":"4","author":"A Gajra","year":"2008","unstructured":"Gajra A, Husain J, Smith A. Lepirudin in the management of heparin-induced thrombocytopenia. Expert Opin Drug Metab Toxicol. 2008;4(8):1131\u201341. https:\/\/doi.org\/10.1517\/17425255.4.8.1131","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"3","key":"7558_CR25","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1056\/NEJMc1510993","volume":"373","author":"A Greinacher","year":"2015","unstructured":"Greinacher A. Heparin-induced thrombocytopenia. N Engl J Med. 2015;373(3):252\u201361. https:\/\/doi.org\/10.1056\/NEJMc1510993","journal-title":"N Engl J Med"},{"issue":"21","key":"7558_CR26","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1182\/blood-2016-11-709873","volume":"129","author":"GM Arepally","year":"2017","unstructured":"Arepally GM. Heparin-induced thrombocytopenia. Blood. 2017;129(21):2864\u201372. https:\/\/doi.org\/10.1182\/blood-2016-11-709873","journal-title":"Blood"},{"issue":"23","key":"7558_CR27","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","volume":"385","author":"NM Van Mieghem","year":"2021","unstructured":"Van Mieghem NM, et al. Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR. N Engl J Med. 2021;385(23):2150\u201360. https:\/\/doi.org\/10.1056\/NEJMoa2111016","journal-title":"N Engl J Med"},{"issue":"4","key":"7558_CR28","doi-asserted-by":"publisher","first-page":"664","DOI":"10.1016\/j.kint.2019.11.027","volume":"97","author":"VK Derebail","year":"2020","unstructured":"Derebail VK, Rheault MN, Kerlin BA. Role of direct oral anticoagulants in patients with kidney disease. Kidney Int. 2020;97(4):664\u201375. https:\/\/doi.org\/10.1016\/j.kint.2019.11.027","journal-title":"Kidney Int"},{"issue":"21","key":"7558_CR29","doi-asserted-by":"publisher","first-page":"2272","DOI":"10.1016\/j.jacc.2016.08.063","volume":"68","author":"Y-H Chan","year":"2016","unstructured":"Chan Y-H, et al. Acute kidney injury in Asians with atrial fibrillation treated with dabigatran or warfarin. J Am Coll Cardiol. 2016;68(21):2272\u201383. https:\/\/doi.org\/10.1016\/j.jacc.2016.08.063","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"7558_CR30","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1016\/j.jacc.2017.10.089","volume":"71","author":"J-I Shin","year":"2018","unstructured":"Shin J-I, et al. Direct oral anticoagulants and risk of acute kidney injury in patients with atrial fibrillation. J Am Coll Cardiol. 2018;71(2):251\u20132. https:\/\/doi.org\/10.1016\/j.jacc.2017.10.089","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"7558_CR31","doi-asserted-by":"publisher","first-page":"385","DOI":"10.2165\/00002018-200629050-00003","volume":"29","author":"L Hazell","year":"2006","unstructured":"Hazell L, Shakir SA. Under-reporting of adverse drug reactions: a systematic review. Drug Saf. 2006;29(5):385\u201396. https:\/\/doi.org\/10.2165\/00002018-200629050-00003","journal-title":"Drug Saf"},{"issue":"7","key":"7558_CR32","doi-asserted-by":"publisher","first-page":"796","DOI":"10.7150\/ijms.6048","volume":"10","author":"T Sakaeda","year":"2013","unstructured":"Sakaeda T, et al. Data mining of the public version of the FDA Adverse Event Reporting System. Int J Med Sci. 2013;10(7):796. https:\/\/doi.org\/10.7150\/ijms.6048","journal-title":"Int J Med Sci"},{"key":"7558_CR33","doi-asserted-by":"crossref","unstructured":"Hartnell NR, Wilson JP. Replication of the Weber effect using postmarketing adverse event reports voluntarily submitted to the United States Food and Drug Administration. 2004, Wiley Online Library.","DOI":"10.1592\/phco.24.8.743.36068"},{"key":"7558_CR34","doi-asserted-by":"publisher","first-page":"891","DOI":"10.2165\/00002018-200730100-00007","volume":"30","author":"A Pariente","year":"2007","unstructured":"Pariente A, et al. Impact of safety alerts on measures of disproportionality in spontaneous reporting databases the notoriety bias. Drug Saf. 2007;30:891\u20138. https:\/\/doi.org\/10.2165\/00002018-200730100-00007","journal-title":"Drug Saf"},{"key":"7558_CR35","doi-asserted-by":"publisher","first-page":"1117","DOI":"10.2165\/11584390-000000000-00000","volume":"33","author":"H-W Wang","year":"2010","unstructured":"Wang H-W, et al. An experimental investigation of masking in the US FDA adverse event reporting system database. Drug Saf. 2010;33:1117\u201333. https:\/\/doi.org\/10.2165\/11584390-000000000-00000","journal-title":"Drug Saf"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07558-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-024-07558-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-024-07558-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,27]],"date-time":"2025-05-27T09:22:09Z","timestamp":1748337729000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-024-07558-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,6]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["7558"],"URL":"https:\/\/doi.org\/10.1007\/s10557-024-07558-0","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,6]]},"assertion":[{"value":"23 January 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"No ethical approval is required for studies conducted on pharmacovigilance databases.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"Not applicable for studies conducted on pharmacovigilance databases.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"Not applicable for studies conducted on pharmacovigilance databases.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}